Skip to main content

Table 4 Analysis of pathologic features for the correlation with SMAD4 mutation of PDAC

From: Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics

Characteristics

Non-SMAD4-mutated PDAC (n = 204)

SMAD4-mutated PDAC (n = 224)

P value

Histologic grade

  

0.951

   Well-differentiated

5(2.45%)

5(2.23%)

 

   Moderately differentiated

120(58.82%)

135(60.27%)

 

   Ill-differentiated

79(38.73%)

84(37.5%)

 

Pathological fatty infiltration

  

0.016

   Absence

53(25.98%)

37(16.52%)

 

   Presence

151(74.02%)

187(83.48%)

 

Pathological peripheral nerve infiltration

  

0.039

   Absence

48(23.53%)

35(15.63%)

 

   Presence

156(76.47%)

189(84.38%)

 

Pathological lymphovascular invasion

  

0.249

   Absence

154(75.49%)

158(70.54%)

 

   Presence

50(24.51%)

66(29.46%)

 

Ki-67 expression status

  

0.490

   ≥ 50%

120(58.82%)

125(55.8%)

 

   < 50%

83(40.69%)

99(44.2%)

 
  1. PDAC = pancreatic ductal adenocarcinoma, BMI = body mass index, HBP = high blood pressure; TBil = total bilirubin, CA 19 − 9 = cancer antigen 19 − 9